Samsca

Samsca is a brand name of tolvaptan, approved by the FDA in the following formulation(s):

SAMSCA (tolvaptan - tablet; oral)

• 
  Manufacturer: OTSUKA AMERICA PHARM
  
  Approval date: May 19, 2009
  
  Strength(s): 15MG, 30MG ^[RLD]

Has a generic version of Samsca been approved?

No. There is currently no therapeutically equivalent version of Samsca available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Samsca. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Benzoheterocyclic compounds
  Patent 5,753,677
  Issued: May 19, 1998
  Inventor(s): Ogawa; Hidenori & Miyamoto; Hisashi & Kondo; Kazumi & Yamashita; Hiroshi & Nakaya; Kenji & Komatsu; Hajime & Tanaka; Michinori & Kora; Shinya & Tominaga; Michiaki & Yabuuchi; Yoichi
  Assignee(s): Otsuka Pharmaceutical Co., Ltd.
  Novel benzoheterocyclic compounds of the formula: ##STR1## which have excellent vasopressin antagonistic activities and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.
  
  Patent expiration dates:
  
  
  • May 19, 2015
    
    ✓ 
    Patent use: METHOD OF TREATING HYPONATREMIA
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • May 19, 2014 - NEW CHEMICAL ENTITY
  
  

See also...

• Samsca Consumer Information (Drugs.com)
• Samsca Consumer Information (Wolters Kluwer)
• Samsca Consumer Information (Cerner Multum)
• Samsca Advanced Consumer Information (Micromedex)
• Samsca AHFS DI Monographs (ASHP)
• Tolvaptan Consumer Information (Wolters Kluwer)
• Tolvaptan Consumer Information (Cerner Multum)
• Tolvaptan Advanced Consumer Information (Micromedex)
• Tolvaptan AHFS DI Monographs (ASHP)